APA (7th ed.) Citation

A, A., AL, F., AR, P., K, P., J, H., E, A., . . . F, M. (2019). Aberrant receptor tyrosine kinase signaling in lipofibromatosis: A clinicopathological and molecular genetic study of 20 cases. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 32(3), 423. https://doi.org/10.1038/s41379-018-0150-3

Chicago Style (17th ed.) Citation

A, Al-Ibraheemi, Folpe AL, Perez-Atayde AR, Perry K, Hofvander J, Arbajian E, Magnusson L, Nilsson J, and Mertens F. "Aberrant Receptor Tyrosine Kinase Signaling in Lipofibromatosis: A Clinicopathological and Molecular Genetic Study of 20 Cases." Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc 32, no. 3 (2019): 423. https://doi.org/10.1038/s41379-018-0150-3.

MLA (9th ed.) Citation

A, Al-Ibraheemi, et al. "Aberrant Receptor Tyrosine Kinase Signaling in Lipofibromatosis: A Clinicopathological and Molecular Genetic Study of 20 Cases." Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc, vol. 32, no. 3, 2019, p. 423, https://doi.org/10.1038/s41379-018-0150-3.